Promising influences of Scutellaria baicalensis and its two active constituents, baicalin, and baicalein, against metabolic syndrome: A review

Vafa Baradaran Rahimi,Vahid Reza Askari,Hossein Hosseinzadeh

DOI: https://doi.org/10.1002/ptr.7046

IF: 6.388

2021-02-16

Phytotherapy Research

Abstract:<p>Metabolic syndrome is known as a group of metabolic abnormalities with features including central obesity, insulin resistance, hypercholesterolemia, hypertriglyceridemia, and hypertension as well as low level of high‐density lipoprotein (HDL)‐cholesterol. Previous studies showed the ameliorating effects of <i>Scutellaria baicalensis</i> on metabolic syndrome parameters, including antidiabetic, anti‐hyperlipidemic, anti‐obesity, and antihypertensive. In this review, we deeply and mechanistically evaluated different studies on the effect of <i>S. baicalensis</i> and its two major bioactive constituents, baicalin, and baicalein, on the critical components of metabolic syndrome, including diabetes, hyperlipidemia, obesity, hypertension, and atherosclerosis. Scientific databases, including PubMed, Scopus, and Google Scholar were searched in the English language until the end of June 2020. Accordingly, <i>S. baicalensis,</i> and its two major bioactive constituents, baicalin and baicalein, represent promising effects on the control of metabolic syndrome and its related disorders such as obesity, hyperlipidemia, atherosclerosis, diabetes, and their following complications. In summary, our findings show that <i>S. baicalensis</i> and its active constituents, baicalin and baicalein, by activation and upregulation of AMPK and PPAR‐γ as the main signaling in the hemostasis of glucose and lipid metabolisms may be favorable candidates for the prevention and treatment of the metabolic syndrome.</p>

pharmacology & pharmacy,chemistry, medicinal